(MENAFN- GlobeNewsWire - Nasdaq) Europe's defibrillator market is driven by aging populations, cardiac disease, public-access AED programs, portable devices, remote monitoring, and expanding home and emergency careDublin, Sept. 22, 2026 (GLOBE NEWSWIRE) -- "Europe Defibrillator Market Report by Product, End User, Countries and Companies Analysis 2026-2034" has been added to ResearchAndMarkets.com's offering.
The Europe defibrillator market is forecast to increase from US$ 4.15 billion in 2025 to US$ 7.76 billion by 2034, expanding at a compound annual growth rate of 7.20% from 2026 to 2034. Market growth is being supported by the rising prevalence of cardiovascular disease, Europe's aging population, wider deployment of automated external defibrillators (AEDs), technological innovation and sustained investment in emergency cardiac care.
Demand for implantable and external defibrillators continues to increase across hospitals, emergency medical services, public-access locations and home healthcare settings. Governments, healthcare providers and private organizations are expanding access to AEDs in airports, schools, workplaces, sports facilities, shopping centers and transportation hubs. Guidelines from organizations such as the European Resuscitation Council are also supporting cardiopulmonary resuscitation training and community-based AED deployment.
Cardiovascular Disease Burden Supports Market Demand
Cardiovascular disease remains a major cause of mortality throughout Europe, creating sustained demand for rapid-response cardiac technologies. According to figures attributed to the Organisation for Economic Co-operation and Development, Bulgaria records more than 900 deaths per 100,000 people from circulatory diseases. Romania reports approximately 780-800 deaths per 100,000 people, followed by Latvia at around 720-750 and Lithuania at approximately 650-700. Hungary records an estimated 600-650 cardiovascular deaths per 100,000 people.
Smoking, obesity, hypertension, alcohol consumption, delayed diagnosis and unequal access to specialist care contribute to the elevated disease burden in several Central and Eastern European countries. Regional disparities are particularly significant in rural communities, where emergency response times, specialist infrastructure and access to advanced cardiac devices may be limited.
Europe's demographic profile is another important market driver. In January 2025, the European Union's population was estimated at 450.6 million, with 22% aged 65 or older. As older adults face an increased incidence of arrhythmias, heart failure and sudden cardiac arrest, healthcare systems are strengthening clinical and community emergency response capabilities.
Public-Access Defibrillation Programs Accelerate Adoption
Government-backed public-access defibrillation programs are expanding AED availability across European communities. Policies in several countries encourage or require defibrillator installation in high-traffic locations, while public funding, grants and private-sector partnerships are improving access in underserved areas.
In England, the government announced a £1 million community defibrillator fund in December 2022, targeting the placement of approximately 1,000 AEDs in locations with significant need. Similar initiatives across Europe are improving emergency preparedness while encouraging broader CPR and AED training. Better device registration and integration with emergency dispatch systems could further improve response times and utilization.
Technology Advances Reshape the Europe Defibrillator Market
Product innovation is improving defibrillator connectivity, reliability and clinical performance. Current systems increasingly include real-time CPR feedback, automated rhythm analysis, remote monitoring, digital data recording, maintenance alerts and wireless connectivity. Improvements in battery longevity, portability and device durability are also supporting adoption outside traditional hospital environments.
Recent European product developments include MicroPort CRM's April 2024 launch of the TALENTIA and ENERGYA implantable cardioverter defibrillator and cardiac resynchronization therapy defibrillator platforms, featuring Bluetooth connectivity and advanced monitoring. MicroPort also expanded European approval for upgraded remote-monitoring systems in January 2024 and launched the SmartView Connect application in March 2025.
In February 2026, BIOTRONIK introduced its Acticor Sky and Rivacor Sky ICD and CRT-D platforms, followed by the first commercial European implantation of a Rivacor Sky CRT-D in Germany. In April 2026, AliveCor launched its Kardia 12L artificial intelligence-enabled ECG system in Europe, supporting earlier identification of cardiac conditions that may require clinical intervention.
Implantable and External Defibrillator Market Outlook
The Europe implantable defibrillator market is expanding as healthcare providers increase the use of ICDs and CRT-Ds for patients with arrhythmias, cardiomyopathy, heart failure and elevated risk of sudden cardiac death. Germany, France and the United Kingdom remain prominent markets due to their established cardiac care networks, reimbursement systems and adoption of advanced medical technologies. Device miniaturization, longer battery life and remote patient monitoring are expected to support continued growth.
External defibrillators are experiencing strong demand through public-access programs and emergency medical services. AED installations are increasing in schools, offices, airports, railway stations and recreational facilities, while manual and semi-automatic systems remain essential in ambulances, emergency departments and acute-care environments.
Hospitals represent a leading end-user segment because of the volume of cardiac emergencies, surgical procedures and intensive-care cases they manage. In February 2024, Royal Papworth Hospital NHS Foundation Trust became the first hospital in Europe outside clinical trials to implant a new ICD platform, demonstrating continued innovation in hospital-based cardiac care.
Home healthcare is also emerging as an important growth segment. Portable and wearable defibrillator solutions are gaining attention among patients who require ongoing cardiac risk management but may not be candidates for implantable devices. Telemedicine, remote monitoring and the broader shift toward decentralized care are expected to strengthen this segment.
Country-Level Market Trends
Germany maintains a leading position in the Europe defibrillator market because of its advanced hospital infrastructure, comprehensive insurance coverage and high adoption of ICDs and public-access AEDs. France benefits from mandatory AED placement policies, public awareness initiatives, favorable reimbursement and strong clinical research capabilities.
The United Kingdom market is supported by the National Health Service, government funding and initiatives led by organizations such as the British Heart Foundation. AED deployment across schools, transportation centers and commercial locations continues to expand, while home and wearable cardiac technologies are gaining traction. Russia presents longer-term growth potential as emergency healthcare infrastructure develops, although regional disparities, funding constraints and limited access to trained personnel remain barriers.
Market Challenges
High acquisition and maintenance costs continue to constrain adoption, particularly among smaller healthcare facilities, schools and public institutions. Battery replacement, electrode pads, software upgrades and servicing requirements add to total ownership costs. Funding and reimbursement policies also vary considerably across Europe, limiting deployment in economically disadvantaged regions.
Training gaps, limited public confidence and uneven device distribution present additional challenges. AED availability is generally stronger in urban areas than in rural communities, and some installed devices are not fully integrated with emergency mapping or dispatch platforms. Expanded training, multilingual guidance, centralized AED registries and coordinated infrastructure planning will be important for improving utilization and clinical outcomes.
Europe Defibrillator Market Segmentation
By product:
Implantable defibrillators External defibrillators
By end user:
Hospitals Pre-hospital services Public-access locations Alternate care facilities Home healthcare
Geographic coverage:
France Germany Italy Spain United Kingdom Belgium Netherlands Russia Poland Greece Norway Romania Portugal Rest of Europe
Competitive Landscape
Major participants in the Europe defibrillator market include Medtronic Plc., Philips Healthcare, Nihon Kohden Corporation, Boston Scientific Corporation, Stryker Corporation, Asahi Kasei Corporation, LivaNova PLC and Abbott. Competitive analysis encompasses company overviews, leadership, recent developments, SWOT assessments and revenue performance.
The market outlook remains positive as Europe strengthens cardiac emergency preparedness, expands public-access AED networks and adopts connected implantable technologies. Continued investment in affordability, training, remote monitoring and equitable regional distribution will be critical to sustaining growth and improving survival outcomes across the continent.
Key Attributes
CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager...
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Comments
No comment